Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue

European Journal of Cancer Part A

Volumn 32, Issue 12, 1996, Pages 2120-2126

  Gordge, P C ^a   Hulme, M J ^a   Clegg, R A ^b   Miller, W R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b HANNAH RESEARCH INSTITUTE   (United Kingdom)

Author keywords

breast cancer; normal breast; protein kinase A; protein kinase C

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN KINASE C;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CALCIUM; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MIDDLE AGED; PROTEIN KINASE C;

EID: 0000939974     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00255-9     Document Type: Article

References (26)

1. 1. Hecker E. Cell membrane associated protein kinase C as receptor of diterpene ester co-carcinogens of the tumor promoter type and the phenotypic expression of tumors. Arzneim-Forsch Drug Res 1985, 35, 1890-1903.
2. 2. Cho-Chung YS. Role of cyclic AMP receptor proteins in growth, differentiation and suppression of malignancy: new approaches to therapy. Cancer Res 1990, 50, 7093-7100.
3. 3. Taylor SS, Radzio-Andzelm E. Cyclic AMP-dependent protein kinase. In Woodgett JR, ed. Protein Kinases. New York, Oxford University Press, 1994, 1-29.
4. 4. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992, 258, 607-614.
5. 5. Miller WR, Elton RA, Dixon JM, Chetty U, Watson DMA. Cyclic AMP binding proteins and prognosis in breast cancer. Br J Cancer 1990, 61, 263-266.
6. 6. Miller WR, Hulme MJ, Cho-Chung YS, Elton RA. Types of cyclic AMP binding proteins in human breast cancers. Eur J Cancer 1993, 29A, 989-991.
7. 7. O'Brian CA, Vogel VG, Singletary SE, Ward NE. Elevated protein kinase C expression in human breast tumour biopsies relative to normal breast tissue. Cancer Res 1989, 49, 3215-3217.
8. 8. Ways DK, Kukoly CA, deVente J, et al. MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 1995, 95, 1906-1915.
9. 9. Cheng HC, Kemp BE, Pearson RB, et al. A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem 1986, 261, 989-992.
10. 10. Connor K, Clegg RA. Isozymes of protein kinase C in rat mammary tissue: changes in properties and relative amounts during pregnancy and lactation. Biochem J 1993, 291, 817-824.
11. 11. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principles of protein-dye binding. Analyt Biochem 1976, 72, 248-254.
12. 12. Murray KJ, England PJ, Lynham JA, Mills D, Schwatz-Peifer C, Reeves MC. Use of a synthetic decapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. Biochem J 1990, 267, 703-708.
13. 13. Pomerantz AH, Rudolph SA, Haley BE, Greengard P. Photoaffinity labelling of a protein kinase from bovine brain with 8-azidoadenosine-3′:5′-monophosphate. Biochemistry 1975, 14, 3858-3862.
14. 14. Laemmeli UK. Cleavage of structured protein during the assembly of the head of bacteriophage T4. Nature (London) 1970, 227, 680-685.
15. 15. Dekker LV, Parker PJ. Protein kinase C - a question of specificity. Trends Biochem Sci 1994, 19, 73-77.
16. 16. Handschin JC, Handloser K, Takahashi A, Eppenberger U. Cyclic adenosine 3′,5′, monophosphate receptor proteins in dysplastic and neoplastic human breast tissue cytosol and their inverse relationship with estrogen receptor. Cancer Res 1983, 43, 2945-2954.
17. 17. Skalhegg BS, Landmark B, Foss KB, et al. Identification, purification and characterization of subunits of cAMP-dependent protein kinase in human testis. J Biol Chem 1992, 267, 5374-5379.
18. 18. Battersby S, Anderson TJ, Miller WR. Patterns of cyclic AMP binding in normal human breast. Breast Cancer Res Treat 1994, 30, 153-158.
19. 19. Houge G, Cho-Chung YS, Doskeland SO. Differential expression of cAMP-kinase subunits is correlated with growth in rat mammary carcinomas and uterus. Br J Cancer 1992, 66, 1022-1029.
20. 20. Houge G, Vintermyr OK, Doskeland SO. The expression of cAMP-dependent kinase in primary rat hepatocyte cultures. Cyclic AMP down-regulates its own effector system by decreasing the amount of catalytic subunit and increasing the inhibitory (R) subunits of cAMP-dependent kinase. Mol Endocrinol 1990, 4, 481-488.
21. 21. Kahl-Rainer P, Karner-Hanusch J, Weiss W, Marian B. Five of six protein kinase C isozymes show reduced protein levels during tumour development in the human colon. Carcinogenesis 1994, 15, 779-782.
22. 22. Pongracz J, Clark P, Neoptolemos JP, Lord JM. Expression of protein kinase C isozymes in colorectal cancer tissue and their differential activation by different bile acids. Int J Cancer 1995, 61, 35-39.
23. 23. O'Brian CA, Liskamp RM, Solamon DH, Weinstein IB. Inhibition of protein kinase C by tamoxifen. Cancer Res 1985, 45, 2462-2465.
24. 24. O'Brian CA, Housey GM, Weinstein IB. Protein kinase C binds specifically and directly to an immobilised tamoxifen analogue. Cancer Res 1988, 48, 3626-3629.
25. 25. Lippman ME, Dickson RB, Gelmann EP, et al. Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J Cell Biochem 1987, 35, 1-16.
26. Iα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res 1993, 53, 868-872.